The AABB Annual Meeting is the principal gathering of the transfusion medicine and biotherapies field, run by the Association for the Advancement of Blood & Biotherapies, the former American Association of Blood Banks, which retained the AABB acronym after its rebrand. It combines scientific and education sessions, standards and accreditation programming, and an exhibit hall spanning blood collection, testing, component storage, and cellular and gene therapies. The 2027 edition is the association's yearly flagship, dated 16-18 October in Anaheim.
This is where the standards that govern handling of temperature-sensitive blood components and cellular therapies are debated and codified; AABB Standards drive accreditation for US and international blood establishments. Sessions on regulatory developments, quality management, and operational best practice directly shape how blood products and biotherapies must be stored, monitored, and transported under cold chain.
The room holds blood bank and transfusion service directors, medical and laboratory directors, quality and regulatory staff, cellular therapy and biotherapies specialists, and researchers, alongside supplier and industry representatives. Seniority skews toward medical directors, lab managers, and accreditation and quality leads from hospital blood banks, blood centers, and reference laboratories.
Be the first to raise your hand.